Bausch Health Companies BHC Fair Value Measurement Disclosure
Fair Value Measurement Disclosure at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's fair value measurement disclosure.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's fair value measurement disclosure?
- Bausch Health Companies (BHC) reported fair value measurement disclosure of $293M in Q1 2026.
- How has Bausch Health Companies's fair value measurement disclosure changed year-over-year?
- Bausch Health Companies's fair value measurement disclosure decreased by 13.6% year-over-year, from $339M to $293M.
- What is the long-term trend for Bausch Health Companies's fair value measurement disclosure?
- Over 4 years (2021 to 2025), Bausch Health Companies's fair value measurement disclosure has grown at a 4.9% compound annual growth rate (CAGR), from $241M to $292M.
- What does fair value measurement disclosure mean?
- This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring or non-recurring basis. It provides transparency into the valuation techniques and inputs used to determine these values, categorized by the fair value hierarchy. This is critical for asset managers holding diverse investment portfolios.